Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ATXI | US
-0.10
-3.45%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
12/09/2024
2.80
3.22
3.22
2.62
Avenue Therapeutics Inc. a specialty pharmaceutical company develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201 which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics Inc. was incorporated in 2015 and is based in Tampa Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
69.1%1 month
87.6%3 months
79.7%6 months
104.2%0.08
17.99
0.85
-
-
-0.42
-
-
-
4.47M
4.47M
-
-
-76.30
-
-535.10
0.59
3.29
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.05
Range1M
1.18
Range3M
1.68
Rel. volume
0.73
Price X volume
56.97K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.3674 | 3.61M | 5.24% | n/a | 83.11% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.17 | 3.23M | -3.06% | n/a | 8.44% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 4.19 | 3.12M | 4.23% | 0.03 | 187.62% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.6 | 3.01M | 11.11% | n/a | 144.16% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.9768 | 2.49M | 0.70% | n/a | 4.26% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.66 | 2.09M | 6.62% | n/a | 19.00% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.16 | 2.01M | 1.29% | n/a | -104.44% |
Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0018 | 1.84M | 0.00% | n/a | -22.64% |
Lml Ltd Dematerialised | LMLLF | Drug Manufacturers-Specialty & Generic | 0.0151 | 1.54M | 17.05% | n/a | -98.67% |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.83 | 1.12M | -12.63% | n/a | -2.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.45 | 4.16M | 9.46% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.29 | 3.57M | 2.79% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.215 | 2.95M | -0.78% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.5 | 860.26K | -5.66% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.25 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.42 | - | Cheaper |
Ent. to Revenue | - | - | - |
PE Ratio | 0.08 | 28.13 | Cheaper |
Price to Book | 0.85 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 79.68 | - | Par |
Debt to Equity | - | -0.91 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | 4.47M | - | Emerging |